Skip to main content

Table 1 Comparison of demographic characteristics of patients with COVID-19 in two groups (hypertensive and normotensive patients)

From: Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?

Variable hypertensive (N: 176) Non-hypertensive (N:422) P-value
Age (Year) 58.21 ± 22.5 56.15 ± 20.2 0.18
BMI (kg/m2) 28.62 ± 4.6 28.01 ± 4.3 0.13
Sex (male) 115(65.3%) 289(68.5%) 0.78
Education    0.65
• < diploma 57 (32.4%) 111(26.3%)  
• >Diploma 119(67.6%) 311 (73.7%)  
Exposure history 30(17%) 191 (45.2%) 0.45
• Contact with patients 118(67%) 250 (59.2%) 0.061
• Go hospital 30(17%) 87(20.6%) 0.23
• Public transportation 24(22.5%) 118(24.1%) 0.64
Comorbidities (positive) 108(61.3%) 249(59%) 0.75
Current smoker 4(2.2%) 12(2.8%) 0.92
Diabetes 72(40.9%) 76(18%) 0.001
CVD 63(35.7%) 44(10.3%) 0.001
MI 4(2.3%) 2(0. 5%) 0.061
Lung diseases 36(20.4%) 52(12.3%) 0.07
Asthma and Allergy 31(17.6%) 67 (15.9%) 0.45
Kidney diseases 25(14.3%) 33(7.8%) 0.013
Liver diseases 10(5.7%) 22(5.2%) 0.47
Cancer 4(2.3%) 8(1.9%) 0.68
Blood Group
• A 55(31.3%) 139(32.8%) 0.21
• B 45(25.5%) 110(26.3%) 0.71
• AB 21(11.9%) 60(14.2%) 0.52
• O 55(31.3%) 113(26.7%) 0.31
Clinical type of COVID- 19 infection on admission
 Severe/Critical type (%) 42(23.8%) 41(9.7%) 0.012
  1. MI: myocardial infarction, CVD: cardiovascular disease